Page 54 - Read Online
P. 54

Page 4 of 8                   Hegazy et al. Vessel Plus 2021;5:46  https://dx.doi.org/10.20517/2574-1209.2021.52





















                Figure 1. A 55-year-old male previously had bilateral partial inferior turbinectomy for persistent nasal obstruction without improvement
                after surgery. (A) presents the left nasal vestibule with a visible collapse of the external nasal valve caused by nasal framework
                disintegration. (B) presents beaded granular nasal mucosa throughout the entire nasal cavity. The patient was referred to a
                rheumatologist and diagnosed with GPA.
























                Figure 2. A 39-year-old male patient with a left maxillary mass invading the left orbital contents. There is evident bony destruction with
                osteoneogenesis. Endoscopic biopsy revealed necrotizing vascular inflammation with extensive necrosis. Red arrow: left nasal mass
                extending intra-orbitally. Yellow arrow: bone destruction of the medial wall of the left maxilla and medial orbital wall.

               including vasculitis, granuloma, and necrosis were found in only 16% of the patients, while only 21% had
               vasculitis and granulomatous changes, and only 23% had vasculitis and necrosis changes [Figure 3]. Thus, a
               negative biopsy does not rule out a diagnosis of ANCA vasculitis. However, a biopsy can still be of value in
               ANCA-negative patients and where other diagnoses, such as malignancy and infection, need to be excluded.
               In cases of generalized involvement, biopsies from other organs such as kidney and skin are more
               sensitive [28,29] .


               Treatment
               A multidisciplinary approach for the management of cases of ANCA-associated vasculitides involving the
               upper respiratory tract is highly recommended.

               Medical treatment
               If there is involvement of a major organ such as lung or kidney or there is life-threatening disease,
               aggressive treatment should be initiated. For localized disease involving sinuses and the upper airway, a less
               aggressive approach can be used. Methotrexate is recommended for induction of remission. Mycophenolate
   49   50   51   52   53   54   55   56   57   58   59